Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature

Vascular Pharmacology

Volumn 51, Issue 4, 2009, Pages 236-245

  Benter, Ibrahim F ^a   Benboubetra, Mustapha ^b,c   Hollins, Andrew J ^b   Yousif, Mariam H M ^a   Canatan, Halit ^a   Akhtar, Saghir ^a,b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c FERHAT ABBAS UNIVERSITY   (Algeria)

Author keywords

AG1478; Diabetes; Mesenteric bed; Microarray; Streptozotocin rats

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CARBOXYPEPTIDASE; COLIPASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; PHOSPHOLIPASE A2; PROTEIN TYROSINE KINASE; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; MALE; MESENTERIC ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; UNINDEXED SEQUENCE; UPREGULATION; VASCULAR DISEASE; VASCULARIZATION;

ANIMALS; DIABETES MELLITUS; GENE EXPRESSION REGULATION; MALE; MESENTERIC ARTERIES; MESENTERIC VEINS; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 70349854540     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.06.008     Document Type: Article

References (48)

1. Abebe W., Harris K.H., and MacLeod K.M. Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J. Cardiovasc. Pharmacol. 16 2 (1990) 239-248
2. Akhtar, S., Almubrad, T., Bron, A.J., Yousif, M.H., Benter, I.F., Akhtar, S., 2009. Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes. Acta Ophthalmol. (Electronic publication ahead of print) PubMed PMID: 19416119.
3. Akiyama N., Naruse K., Kobayashi Y., et al. High glucose-induced upregulation of Rho/Rho-kinase via platelet-derived growth factor receptor-beta increases migration of aortic smooth muscle cells. J. Mol. Cell. Cardiol. 45 2 (2008) 326-332
4. Arita R., Hata Y., Nakao S., Kita T., Miura M., Kawahara S., Zandi S., Almulki L., Tayyari F., Shimokawa H., Hafezi-Moghadam A., and Ishibashi T. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes 58 (1), 215-226 (2009) (Electronic publication ahead of print 2008 Oct 7). PubMed PMID: 18840783; PubMed Central PMCID: PMC2606876
5. Bach L.A. Rho kinase inhibition: a new approach for treating diabetic nephropathy?. Diabetes 57 3 (2008) 532-533
6. Baelde H.J., Eikmans M., Doran P.P., Lappin D.W., de Heer E., and Bruijn J.A. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am. J. Kidney Dis. 43 4 (2004) 636-650
7. Belmadani S., Palen D.I., Gonzalez-Villalobos R.A., Boulares H.A., and Matrougui K. Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice. Diabetes 57 6 (2008) 1629-1637
8. Benter I.F., Yousif M.H., Griffiths S.M., Benboubetra M., and Akhtar S. Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed. Br. J. Pharmacol. 145 6 (2005) 829-836
9. Benter I.F., Yousif M.H., Hollins A.J., Griffiths S.M., and Akhtar S. Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase. J. Vasc. Res. 42 4 (2005) 284-291
10. 2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery. Pharmacol. Res. 52 3 (2005) 252-257 Sep
11. Benter, I.F., Canatan, H., Benboubetra, M., Yousif, M.H., Akhtar, S., 2009. Global upregulation of gene expression associated with renal dysfunction in DOCA-salt induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: A microarray analysis. Vascul Pharmacol. (Electronic publication ahead of print). PubMed PMID: 19410658.
12. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 6865 (2001) 813-820
13. Canatan H. The effect of cardiac ischemic preconditioning on rat left ventricular gene expression profile. Cell. Biochem. Funct. 26 (2008) 179-184
14. Cardozo A.K., Heimberg H., Heremans Y., et al. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J. Biol. Chem. 276 52 (2001) 48879-48886
15. Castoldi G., di Gioia C.R., Pieruzzi F., et al. Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo. J. Hypertens. 19 11 (2001) 2011-2018
16. Garcia M.J., Mcnamara P.M., Gordon T., and Kannel W.B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23 (1974) 105-111
17. Grossmann C., and Gekle M. Nongenotropic aldosterone effects and the EGFR: interaction and biological relevance. Steroids 73 9-10 (2008) 973-978
18. Higuchi S., Ohtsu H., Suzuki H., Shirai H., Frank G.D., and Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin. Sci. (Lond). 112 8 (2007) 417-428
19. Hollins A.J., Omidi Y., Benter I.F., and Akhtar S. Toxicogenomics of drug delivery systems: exploiting delivery system-induced changes in target gene expression to enhance siRNA activity. J. Drug. Target 15 (2007) 83-88
20. Jarrett R.J. Cardiovascular disease and hypertension in diabetes mellitus. Diabetes. Metab. Rev. 5 (1989) 547-558
21. Joussen A.M., Huang S., Poulaki V., et al. In vivo retinal gene expression in early diabetes. Invest. Ophthalmol. Vis. Sci. 42 12 (2001) 3047-3057
22. Knoll K.E., Pietrusz J.L., and Liang M. Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol. Genomics. 21 2 (2005) 222-229
23. Labonté E.D., Kirby R.J., Schildmeyer N.M., Cannon A.M., Huggins K.W., and Hui D.Y. Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia. Diabetes 55 4 (2006) 935-941
24. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., Bourguignon L., and Hung M.C. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell. Biol. 3 9 (2001) 802-808
25. Mannikarottu A.S., Changolkar A.K., Disanto M.E., Wein A.J., and Chacko S. Over expression of smooth muscle thin filament associated proteins in the bladder wall of diabetics. J. Urol. 174 1 (2005) 360-364
26. Mayhan W.G., Irvine S.D., and Sharpe G.M. Constrictor responses of resistance arterioles during diabetes mellitus. Diabetes Res. Clin. Pract. 44 3 (1999) 147-156
27. Mehta P.K., and Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell. Physiol. 292 1 (2007) C82-97
28. Mootha V.K., Lindgren C.M., Eriksson K.F., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 3 (2003) 267-273
29. Omidi Y., Hollins A.J., Benboubetra M., Drayton R., Benter I.F., and Akhtar S. Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells. J. Drug Target. 11 (2003) 311-323
30. Omidi Y., Hollins A.J., Drayton R.M., and Akhtar S. Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type. J. Drug Target. 13 (2005) 431-443
31. Oyama Y., Kawasaki H., Hattori Y., and Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol. 132 1 (1986) 75-78
32. Peng F., Wu D., Gao B., et al. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes 57 6 (2008) 1683-1692
33. Petch A.K., Sohail M., Hughes M.D., Benter I., Darling J., Southern E.M., et al. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides. Biochem. Pharmacol. 66 (2003) 819-830
34. Portik-Dobos V., Harris A.K., Song W., et al. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 2 (2006) R435-441
35. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J. Cell. Physiol. 213 3 (2007) 589-602
36. Strasser P., Gimona M., Moessler H., Herzog M., and Small J.V. Mammalian calponin. Identification and expression of genetic variants. FEBS. Lett. 330 1 (1993) 13-18
37. Sullivan C.J., Teal T.H., Luttrell I.P., Tran K.B., Peters M.A., and Wessells H. Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats. Physiol. Genomics 23 2 (2005) 192-205
38. Tao R.H., and Maruyama I.N. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J. Cell. Sci. 121 Pt 19 (2008) 3207-3217
39. Wassef L., Kelly D.J., and Gilbert R.E. Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes. Kidney Int. 66 (2004) 1805-1814
40. Wilson K.H., Eckenrode S.E., Li Q.Z., et al. Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. Diabetes 52 8 (2003) 2151-2159
41. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2 2 (2001) 127-137
42. Yechoor V.K., Patti M.E., Saccone R., and Kahn C.R. Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc. Natl. Acad. Sci. USA. 99 16 (2002) 10587-10592
43. Yousif M.H., Benter I.F., and Akhtar S. Inhibition of calcium/calmodulin-dependent protein kinase II normalizes diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed. Auton. Autacoid. Pharmacol. 23 1 (2003) 27-33 Feb
44. Yousif M.H., Benter I.F., Abraham S., and Akhtar S. Inhibition of Ras-GTPase improves diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed. Med. Princ. Pract. 13 2 (2004) 57-62 Mar-Apr
45. Yousif M.H., Benter I.F., and Akhtar S. The role of tyrosine kinase-mediated pathways in diabetes-induced alterations in responsiveness of rat carotid artery. Auton. Autacoid. Pharmacol. 25 2 (2005) 69-78
46. Yousif M.H., Benter I.F., Abul A.H., Abraham S., Walther T., and Akhtar S. Inhibition of Ras-GTPase signaling by FPTIII ameliorates development of cardiovascular dysfunction in diabetic-hypertensive rats. Vascul. Pharmacol. 49 4-6 (2008) 151-157 Oct-Dec
47. 2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension. Cell. Biochem. Funct. 26 2 (2008) 256-263 Mar-Apr
48. Yousif M.H., Benter I.F., Hares N., Canatan H., and Akhtar S. Phosphoinositide 3-kinase mediated signalling contributes to development of diabetes-induced abnormal vascular reactivity of rat carotid artery. Cell. Biochem. Funct. 24 1 (2006) 13-22 Jan-Feb